| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |